Alpha Lipoic Acid (α - LA) is a light yellow powdery crystalline substance that is almost odorless and a strong antioxidant. It has a low solubility in water, about 1g/L (20 ° C), but is easily soluble in methanol, ethanol, chloroform, ether, and 10% NaOH solution.

Alpha lipoic acid is distributed in animal and plant tissues, especially abundant in liver and yeast cells. It has many benefits to the human body, such as protecting the heart, improving diabetes, protecting the liver, etc. Due to the decrease in the content of alpha lipoic acid in the human body with age, it can be supplemented through dietary supplements. ‌

Overview of Market Development

According to our research data, the estimated revenue of the global alpha lipoic acid market in 2024 is $124 million, an increase of 6.84% compared to 2023. In the future, with the global aging population, the incidence rate of chronic diseases such as diabetes rising, alpha lipoic acid will be more widely used in medicine and health care products, and the market is expected to continue to expand. It is expected that by 2029, the global market revenue of alpha lipoic acid will increase to $179 million. The CAGR for 2024-2029 is estimated to be 7.62%.

Segmented Market Analysis

From the perspective of type, alpha lipoic acid can be divided into two categories based on its usage and quality standards: medical level and experimental level. Among them, medical level alpha lipoic acid dominates the market, with an estimated market share of 90.11% in 2024.

From the perspective of application, alpha lipoic acid is mainly used in chronic hepatitis treatment, cirrhosis treatment, diabetes treatment, fatty liver treatment, and so on. Among them, the diabetes treatment field occupies the highest share of the downstream application market, which is estimated to be 46.71% in 2024.

Source: www.globalmarketmonitor.com

Market Analysis of Major Regions

From a regional perspective, the Asia Pacific region is the global largest revenue market for alpha lipoic acid. According to the data, the estimated revenue of alpha lipoic acid market in the Asia Pacific region in 2024 is $64.90 million, and the revenue share is expected to reach 52.16%; The European and North American markets are expected to rank second and third with revenue shares of 25.43% and 19.42%, respectively.

Regions	Market Revenue (Million USD)	Revenue Share
North America	24.16	19.42%
Europe	31.64	25.43%
Asia Pacific	64.90	52.16%
Others	3.73	3.00%